NASDAQ : ACON
Aclarion, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 1.95 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.62M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.19M |
| Enterprise Value | -11.11M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 16, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.88M |
| Shares Outstanding | 2.88M |
| Shares Change (YoY) | +154.07% |
| Shares Change (QoQ) | +15.61% |
| Owned by Insiders (%) | 12.56% |
| Owned by Institutions (%) | 4.00% |
| Float | 2.52M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 61.94 |
| Forward PS | 32.40 |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 16.20 |
| Quick Ratio | 15.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -58.97% |
| Return on Assets (ROA) | -37.01% |
| Return on Invested Capital (ROIC) | -38.91% |
| Return on Capital Employed (ROCE) | -57.11% |
| Weighted Average Cost of Capital (WACC) | 10.92% |
| Revenue Per Employee | $7,615 |
| Profits Per Employee | -$836,051 |
| Employee Count | 11 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -76.80% |
| 50-Day Moving Average | 2.31 |
| 200-Day Moving Average | 2.84 |
| Relative Strength Index (RSI) | 32.82 |
| Average Volume (20 Days) | 18,554 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 24,624 |
| Short Previous Month | 48,934 |
| Short % of Shares Out | 0.85% |
| Short % of Float | 0.98% |
| Short Ratio (days to cover) | 0.59 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 83,769 |
| Gross Profit | 18,224 |
| Operating Income | -9.71M |
| Pretax Income | -9.20M |
| Net Income | -9.20M |
| EBITDA | -9.47M |
| EBIT | -9.71M |
| Loss Per Share | -$6.22 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 16.30M |
| Total Debt | n/a |
| Net Cash | 16.30M |
| Net Cash Per Share | $5.65 |
| Equity (Book Value) | 17.00M |
| Book Value Per Share | 6.91 |
| Working Capital | 15.76M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -8.09M |
| Capital Expenditures | -22,856 |
| Depreciation & Amortization | 242,455 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.11M |
| FCF Per Share | -$2.81 |
Margins
| Measure | Value |
|---|
| Gross Margin | 21.76% |
| Operating Margin | -11,592.14% |
| Pretax Margin | -10,978.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -154.07% |
| Shareholder Yield | -154.07% |
| Earnings Yield | -345.30% |
| FCF Yield | -156.31% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 290.97% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:27 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.77 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |